Skip to main content
main-content
Top

12-01-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine

In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19. 

In this episode, Alfred (Al) Kim, a rheumatologist from the Washington University School of Medicine in St Louis, Missouri, USA, talks about hydroxychloroquine. He discusses why the drug was initially considered promising but later shown to be ineffective, and describes the impact drug shortages have had on rheumatology practice.

Listen below or subscribe to this Podcast on:

Google PodcastsApple Podcasts | SpotifyStitcher | TuneIn

About the speaker

Alfred Kim

Dr Alfred Kim is an Assistant Professor of Medicine at Washington University School of Medicine in St Louis, Missouri, USA, where he founded and co-directs the Washington University Lupus Clinic.


Full biography

Repurposing rheumatology drugs for COVID-19

Experts discuss the rationale, data on different agents, and the potential impact on rheumatology practice.

  • » Featuring insights from the COVID-19 Global Rheumatology Alliance, EULAR, and the Lupus Foundation of America
Image Credits